Jason Aryeh, Director at LIGAND PHARMACEUTICALS INC (LGND), bought 1,500 shares at $87.01 ($131K) on 2019-09-03, disclosed to the SEC on 2019-09-04.
Open-market purchase of $131k LGND by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $87.01 | 750 | $65K | 50.0% |
| 2 | $87.01 | 750 | $65K | 50.0% |
| Total | $87.01 avg | 1,500 | $131K | 100% |
| Filing → |
| OBIO | BUY | 2026-05-19 | $35K | — | Filing → |
| LGND | SELL | 2025-09-24 | $3.4M | — | Filing → |
| OBIO | BUY | 2025-09-19 | $2K | — | Filing → |